Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-31

Clinical Trial Update: There is a Value of Luteinizing Hormone Predictive of in Vitro Fertilization Treatment Outcome in Antagonist Protocols? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether luteinizing hormone levels predict IVF outcomes in antagonist protocols; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti | Conditions: Female Infertility | Phase 4 | Status: COMPLETED